Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Medi-Weightloss
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxMedi-Weightloss
Shoppers near one of Medi-Weightloss's 130+ US clinics who want in-person labs and are comfortable with location-dependent pricing.
Visit Medi-WeightlossThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 54. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Medi-Weightloss still earns a C — Shoppers near one of Medi-Weightloss's 130+ US clinics who want in-person labs and are comfortable with location-dependent pricing.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Medi-Weightloss |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 54/100 |
| Semaglutide / mo | $99/mo | $99/mo (starting dose, first-month rate, plus a separate fee, compounded) |
| Tirzepatide / mo | $149/mo | $199/mo (starting dose, first-month rate, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $1,188 |
| Tirzepatide / yr (modeled) | $1,788 | $2,388 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #1 | #358 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Medi-Weightloss
54/100Where the value is
- Over 130 in-person clinic locations across the US with on-site labs and body composition analysis at the new-patient visit
- Publishes real introductory numbers ($99 semaglutide / $199 tirzepatide first month) rather than staying fully opaque
- Insurance path available for branded Zepbound/Wegovy/Saxenda, with the site claiming most insured patients 'pay between $0 and $50 per visit'
The tradeoffs
- The $99/$199 headline figures are explicitly FIRST-MONTH-ONLY; the ongoing self-pay rate 'varies by program and location' and is never published anywhere on the site
- A separate $199 new-patient visit fee is charged before the first month's medication price even applies
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.